GE
Therapeutic Areas
miRoncol Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Real-time Multi-Cancer Early Risk Assessment | Solid Tumors (12+ common types) | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Real-time Multi-Cancer Early Risk Assessment | Solid Tumors (12+ common types) | Preclinical |